Survival of Patients with AIDS and End-Stage Renal Disease Receiving Hemodialysis

Dialysis and Transplantation

Volumn 33, Issue 4, 2004, Pages 176-186

  Ifudu, Onyekachi ^a   Salifu, Moro O ^a   Reydel, Catherine ^b   DiRienzo, Rachel ^b   McClendon, Eunice ^b   Bley, Aimee ^b   Waltrous Jr , Clarence ^b   Oguagha, Chika ^b   Friedman, Eli A ^a  

^a SUNY Downstate Medical Center   (United States)

^b Nephrology Foundation of Brooklyn   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIALYSIS; FEMALE; HEALTH CARE FACILITY; HEMODIALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY FAILURE; LYMPHOCYTE COUNT; MAINTENANCE THERAPY; MALE; MULTICENTER STUDY; OUTCOMES RESEARCH; PATIENT REFERRAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGRESSION ANALYSIS; STATISTICAL ANALYSIS; SURVIVAL; SURVIVAL TIME; UNITED STATES; UREMIA;

EID: 1842731895     PISSN: 00902934     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Winston JA, Klotman PE. Are we missing an epidemic of HIV-associated nephropathy. J Am Soc Nephrol 1996; 7:1-7.
2. Rao TKS, Filippone EJ, Nicastri AD, Landesman SH, Frank E, Chen CK, Friedman EA. Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med 1984; 310:669-673.
3. Rao TKS, Friedman EA, Nicastri AD. The types of renal disease in the acquired immunodeficiency syndrome. N Engl J Med 1987; 316:1062-1068.
4. Rao TK, Manis T, Friedman EA. Dismal prognosis despite maintenance hemodialysis in AIDS nephropathy and chronic uremia. ASAIO Trans 1985; 31:160-163.
5. Carbone L, D'Agati V, Cheng JT, Appel GB. The course and prognosis of human immunodeficiency virus-associated nephropathy. Am J Med 1989; 87:389-395.
6. Ortiz C, Meneses R, Jaffe D, Fernandez JA, Perez G, Bourgoignie JJ. Outcome of patients with human immunodeficiency virus on maintenance hemodialysis. Kidney Int 1988; 34:248-253.
7. Friedman EA (ed.). No dialysis for AIDS nephropathy. In: Legal and Ethical Concerns in Treating Kidney Failure: Case Study Workbook. Dordrecht, The Netherlands: Kluwer Academic Publishers, 2000, pp 60-70.
8. Pennell JP, Bourgoignie JJ. Should AIDS patients be dialyzed? ASAIO Trans 1988; 34:907-911.
9. Norusis MJ. SPSS for Windows Advanced Statistics, Release 8.0 SPSS, Chicago, 1997.
10. United States Renal Data System. USRDS 2001 Annual Data Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2001.
11. Ahuja TS, Borucki M, Grady J. Highly active antiretroviral therapy improves survival of HIV-infected hemodialysis patients. Am J Kidney Dis 2000; 36:574-580.
12. Perinbasekar S, Brod-Miller C, Pal S, Mattana J. Predictors of survival in HIV-infected patients on hemodialysis. Am J Nephrol 1996; 16:280-286.
13. Sansone GR, Frengley JD. Impact of HAART on causes of death of persons with late-stage AIDS. J Urban Health 2000; 77:166-175.
14. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338:853-860.
15. Laraque F, Greene A, Triano-Davis JW, Altman R, Lin-Greenberg A. Effect of comprehensive intervention program on survival of patients with human immunodeficiency virus infection. Arch Intern Med 1996; 156:169-176.
16. Friedman EA. End-stage renal disease therapy: An American success story. JAMA 1996; 275:1118-1122.
17. Ifudu O. Care of patients undergoing hemodialysis. N Engl J Med 1998; 339:1054-1062.
18. Ifudu O. Strategies for maximizing response to erythropoietin in treating HIV-associated anemia. Cleve Clin J Med 2001; 68:643-648.
19. Hakim RA, Breyer J, Ismail N, Schulman G. Effects of dose of dialysis on morbidity and mortality. Am J Kidney Dis 1994; 23:661-669.
20. Brook MG, Miller RF. HIV-associated nephropathy: A treatable condition. Sex Transm Infect 2001; 77:97-100.
21. Viani RM, Dankner WM, Muelenaer PA, Spector SA. Resolution of HIV-associated nephrotic syndrome with highly active antiretroviral therapy delivered by gastrostomy tube. Pediatrics 1999; 104:1394-1396.
22. Wali RK, Drachenberg CI, Papadimitriou JC, Keay S, Ramos E. HIV-1-associated nephropathy and response to highly-active antiretroviral therapy. Lancet 1998; 352:783-784.
23. Eustace JA, Nuermberger E, Choi M, Scheel PJ Jr, Moore R, Briggs WA. Cohort study of the treatment of severe HIV-associated nephropathy with corticosteroids. Kidney Int 2000; 58:1253-1260.
24. Burns GC, Paul SK, Toth IR, et al. Effect of angiotensin-converting enzyme inhibition in HIV-associated nephropathy. J Am Soc Nephrol 1997; 8:1140-1146.
25. Kimmel PL, Mishkin GJ, Umana WO. Captopril and renal survival in patients with human immunodeficiency virus nephropathy. Am J Kidney Dis 1996; 28:202-208.
26. Ifudu O, Rao TKS, Tan CC, Fleischman H, Chirgwin K, Friedman EA. Zidovudine is beneficial in human immunodeficiency virus-associated nephropathy. Am J Nephrol 1995; 15:217-221.
27. Winston JA, Klotman ME, Klotman PE. HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection. Kidney Int 1999; 55:1036-1040.